A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Cardiomyopathy
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Study ID
Protocol Number: 19-0225
More information available at ClinicalTrials.gov: NCT03860935
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers